Menu Search
Equities

Trajan Group Holdings Ltd

TRJ:ASX

Trajan Group Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.975
  • Today's Change-0.01 / -1.02%
  • Shares traded66.20k
  • 1 Year change-20.73%
  • Beta0.9442
Data delayed at least 20 minutes, as of Nov 22 2024 04:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Trajan Group Holdings Ltd's revenues fell -4.40% from 162.15m to 155.02m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 1.89m to a loss of 25.33m.
Gross margin39.10%
Net profit margin-16.34%
Operating margin-17.12%
Return on assets-12.15%
Return on equity-21.80%
Return on investment-16.57%
More ▼

Cash flow in AUDView more

In 2024, Trajan Group Holdings Ltd did not generate a significant amount of cash. However, the company earned 9.48m from its operations for a Cash Flow Margin of 6.11%. In addition the company used 3.04m on investing activities and also paid 6.40m in financing cash flows.
Cash flow per share-0.1072
Price/Cash flow per share--
Book value per share0.6757
Tangible book value per share0.1093
More ▼

Balance sheet in AUDView more

Trajan Group Holdings Ltd has a Debt to Total Capital ratio of 35.32%, a lower figure than the previous year's 38.25%.
Current ratio0.8553
Quick ratio0.4682
Total debt/total equity0.5461
Total debt/total capital0.3532
More ▼

Growth rates in AUD

Year on year, growth in earnings per share excluding extraordinary items dropped -1,450.81%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-1,455.05
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.